Literature DB >> 25610069

Metastatic glucagonoma.

Bulent Dinc1, Cankat Sahin2.   

Abstract

We report a case of a very rare endocrine tumor of the pancreas. The patient is a 53-year-old female who has necrotizing and crusty maculopapular lesions on the upper and lower extremities and was diagnosed with bullous pemphigoid. The patient's symptoms included fatique and weight loss, and examination revealed pale sclera, angular chelitis and glossitis. Because the CA 19-9 and glucagon levels were high, and abdominal dynamic CT showed a mass in the pancreas body and metastatic lesions in the liver, the decision was made to operate. A distal pancreatectomy, splenectomy, cholecystectomy and right trisegmentectomy were performed. The histopathology of the tumor was reported as a neuroendocrine tumor, which was concordant with glucagonoma. The patient died on postoperative day 12 due to liver failure. According to the literature, when safe conditions were obtained, aggressive surgery followed by chemoterapy can increase the survival rate of these patients.

Entities:  

Keywords:  Glucagonoma; Liver; Metastases

Year:  2009        PMID: 25610069      PMCID: PMC4261651     

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  8 in total

1.  Metastatic endocrine tumors: is there a place for liver transplantation?

Authors:  B Dousset; D Houssin; O Soubrane; O Boillot; F Baudin; Y Chapuis
Journal:  Liver Transpl Surg       Date:  1995-03

Review 2.  The glucagonoma syndrome: a review of its features and discussion of new perspectives.

Authors:  M A Chastain
Journal:  Am J Med Sci       Date:  2001-05       Impact factor: 2.378

3.  Metastatic glucagonoma: treatment with liver transplantation.

Authors:  Peter Radny; Thomas Kurt Eigentler; Karsten Soennichsen; Dietrich Overkamp; Hans-Rudolf Raab; Richard Viebahn; Christian Mueller-Horvart; Karl Sotlar; Gernot Rassner
Journal:  J Am Acad Dermatol       Date:  2006-02       Impact factor: 11.527

4.  Glucagonoma syndrome: survival 21 years with concurrent liver metastases.

Authors:  Spyros P Dourakis; Alexandra Alexopoulou; Kleoniki K Georgousi; Johanna K Delladetsima; George Tolis; Athanasios J Archimandritis
Journal:  Am J Med Sci       Date:  2007-09       Impact factor: 2.378

5.  Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.

Authors:  Juan M Sarmiento; Glenroy Heywood; Joseph Rubin; Duane M Ilstrup; David M Nagorney; Florencia G Que
Journal:  J Am Coll Surg       Date:  2003-07       Impact factor: 6.113

6.  Aggressive surgery for metastatic liver neuroendocrine tumors.

Authors:  Jeffrey A Norton; Robert S Warren; Mary G Kelly; Marlene B Zuraek; Robert T Jensen
Journal:  Surgery       Date:  2003-12       Impact factor: 3.982

7.  The glucagonoma syndrome. Clinical and pathologic features in 21 patients.

Authors:  R A Wermers; V Fatourechi; A G Wynne; L K Kvols; R V Lloyd
Journal:  Medicine (Baltimore)       Date:  1996-03       Impact factor: 1.889

Review 8.  Islet cell tumors of the pancreas: the medical oncologist's perspective.

Authors:  R Brentjens; L Saltz
Journal:  Surg Clin North Am       Date:  2001-06       Impact factor: 3.537

  8 in total
  1 in total

1.  Case of delayed diagnosis of necrolytic migratory erythema.

Authors:  Wissal Abdelli; Fatima Alaoui; Asmahen Souissi; Wiem Sassi; Ines Chelly; Slim Haouet; Mourad Mokni
Journal:  Clin Case Rep       Date:  2021-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.